Navigation Links
Quest Diagnostics MedPlus Subsidiary Enables New York Clinical Information Exchange (NYCLIX) to Share Meaningful Data and Enhance Patient Care
Date:7/20/2009

Patient-Based Record Improves Quality, Safety and Efficiency

MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- MedPlus, the healthcare information technology subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced that NYCLIX is now sharing key patient data electronically among ten unaffiliated healthcare organizations across New York City using the company's Centergy(TM) suite of integrated health information exchange (HIE) solutions. NYCLIX partner hospitals and physicians now have the opportunity to enhance the quality, safety and efficiency of patient care by accessing in real time clinical information using a patient-based record that is accessible through interoperable hospital network and Electronic Health Record (EHR) technologies.

NYCLIX partner healthcare institutions record 840,000 emergency visits annually, as well as 470,000 discharges, 6.8 million outpatient visits and 5.9 million home visits. NYCLIX's vision is a healthcare system that facilitates patients' access to care; improves quality, safety and efficiency; and empowers consumers through improved access to information, all while preserving patient privacy.

"Successful interoperability between various systems is key to a large-scale HIE initiative such as ours," said Gilad J. Kuperman, MD, PhD, chairman of the NYCLIX board and director of Interoperability Informatics at New York-Presbyterian Hospital. "Our participating organizations include some of the largest hospitals in the most populous American city, and between inpatient and emergency department visits, account for more than a million encounters annually. As a partner, MedPlus was instrumental in not only interfacing a multitude of departmental and ancillary systems into a centralized and easy-to-use frontend, but also
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Five-Question Test Helps Assess Asthma Control In Children Under Five Years Of Age
2. New Five-Question Test Helps Assess Asthma Control in Children Under Five Years of Age
3. Quest Diagnostics To Release Second Quarter Financial Results
4. AUL President to Senate Judiciary Committee: Ask Top 10 Questions to Judge Sotomayor
5. Questions to Pharmacists Rise After Michael Jacksons Death
6. A Bundle of Joy Brings a Bundle of Questions - Life123.com Delivers the Answers!
7. European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
8. Quest International Repeats Win as Siemens Healthcare Best Global Supplier of the Year
9. Recent News Reports of Sweetener Reformulations Raise Questions About Motivations
10. Media Alert: Questions Remain in Michael Jackson Autopsy - College of American Pathologists Has Forensic Pathologist Available to Answer Reporter Questions
11. The Vegan Monologues Asks the Burning Question: Is That a Carrot in Your Pocket?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...c. 4 While Congress deb...th care costs, Leapfrog,s purchaser members point ...ering the best quality care in the nation while at...our urban, eight children,s and three rural hospit...ased on results from The Leapfrog Hospital Survey....
(Date:12/4/2009)...tists at Johns Hopkins publishing in the December ...e by a gene called "Twist" may be the proverbial r... that drive aggressive, metastatic breast cancer f...ent work suggesting that it is a relatively rare s... breast cancer, scientists have surmised that this...
(Date:12/4/2009)...ntal tourism is a phenomenon that was started by p...high price of dental work in the US, Canada, and o...ental care, people have found that Mexican Dental ...tination. , (PRWEB) Decem...an 6 years, Mexican Dental Vacation is seeing thei...
(Date:12/4/2009)...RNewswire/ -- Substantial progress has been made o...s ability to diagnose and treat epilepsy and its c...ement has not reached most of the 50 million peopl...hree million people in the United States who have ...er, M.D., president of the American Epilepsy Socie...
(Date:12/4/2009)...ering drugs known as statins are among the most pr...researchers at Fred Hutchinson Cancer Research Cen...ransplant patients from one of the most serious co...ft-versus-host disease, or GVHD. The findings are ...l Blood . , In a retrospective study of 567 pati...
Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2
...r osteoarthritis of the knee back to the future.Th...helps relieve pain and other symptoms better than ...ation of leeches to treat pain is an ancient medic...s, such as in treating postoperative complications...
...by viral cold are common in preschoolers. These at... frequency disappears by school age. //The current...eroids at the first sign of an attack. But whether...atory symptoms or the need for hospital admission....
...diagnosed with type 2 diabetes and now research sh...eater risk for a heart attack and stroke. //Specif...d with type 2 diabetes are 14-times more likely to...oing to get heart disease, heart attacks and strok...
...soon be fighting a losing battle. Scientists from ...uccessfully stopped the tuberculosis pathogen's ab...cally hides out in the immune system in a cell cal...s TB. Thus far, all of the research has been done ...
...on condition that can be fatal. It is defined as a...lly due to a blood clot, //which blocks a coronary...for a pulmonary embolism, a new study shows a new ...t 600,000 Americans develop a pulmonary embolism a...
...eir mouths. But as children get older, they become...y if they have not tried it before. Green veget... scientists say thousands of years ago toxins in p...ous of certain food types as youngsters. Resear...
Other Medicine News:
(Date:12/4/2009)...Neb., Dec. 4 Amber Pharmacy announ...creditation Commission for Health Care, Inc. (ACHC... years, Amber Pharmacy has provided comprehensive ...ique needs of specialized conditions. Amber Pharma...transplant programs. They work with over 170 trans...
(Date:12/4/2009)...AKE CITY, Dec. 4 Dynatro... signed a sole-source vendor agreement to provide ...Physical Therapy with 65 clinics located in Tennes...d the sole-source supplier to Benchmark Physical T...esident of sales and marketing at Dynatronics. "Be...
(Date:12/4/2009)..., WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ ...eport published by the Pharmaceutical Research a...fies 97 new drugs and vaccines in development for ...ort found that the 97 products in development inc...e either in human clinical trials or awaiting appr...
Breaking Medicine Technology:Amber Pharmacy Earns Accreditation From ACHC 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 1FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 2FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 3FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 4FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 5FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 6FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 7U S Census Bureau Daily Feature for July 21 52174 1UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 1UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 2UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 3UPDATE 3A US Oncology Research Network Participates in Phase III Follow up Study to BiPars Investigational Cancer Drug BSI 201 4753 4
...07 /CNW/ - Protox,Therapeutics Inc. (TSX-V:PRX) to...Phase 1 clinical trial evaluating ,PRX302 in patie...owing radiation failure. The trial results indica...ws promising signs,of therapeutic activity followi...The completion of the PRX302 Phase 1 trial is enco...
...P-233) Ability to Clear Brain,Plaque and Empower R...o ,Proof of Concept, Study Proposes Direct Correla...ry Recovery , LAS VEGAS, July 10, 2007 (PRIME NEWS..., a developer of innovative drugs,is pleased to a...ficacy in its ability to dramatically decrease bet...
Other Medicine Technology:Protox Announces Positive Clinical Data from Prostate Cancer Study 2Protox Announces Positive Clinical Data from Prostate Cancer Study 3Protox Announces Positive Clinical Data from Prostate Cancer Study 4Protox Announces Positive Clinical Data from Prostate Cancer Study 5Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 2Samaritan's Alzheimer's Drug Caprospinol Suggests Brain May be Able,to Heal From Alzheimer's Disease 3
Surgiflex® WAVE XP™ Handpiece and Pump, without probe shaft
Surgiflex® WAVE XP™ Handpiece and Pump
SUCTION IRRIGATION: StrykeFlow PS
SUCTION IRRIGATION: StrykeFlow 2
Medicine Products: